<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34826032</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>21</Day></DateCompleted><DateRevised><Year>2022</Year><Month>08</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1590-3478</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>May</Month></PubDate></JournalIssue><Title>Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology</Title><ISOAbbreviation>Neurol Sci</ISOAbbreviation></Journal><ArticleTitle>Blood-brain barrier dysfunction and myelin basic protein in survival of amyotrophic lateral sclerosis with or without frontotemporal dementia.</ArticleTitle><Pagination><StartPage>3201</StartPage><EndPage>3210</EndPage><MedlinePgn>3201-3210</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10072-021-05731-z</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We aim to investigate blood-brain barrier (BBB) dysfunction and myelin basic protein (MBP) in amyotrophic lateral sclerosis (ALS) with or without frontotemporal dementia (FTD) and further determine the effect of these factors on the survival of ALS.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This was a retrospective study of 113 ALS patients, 12 ALS-FTD patients, and 40 disease controls hospitalized between September 2013 and October 2020. CSF parameters including total protein (TP), albumin (Alb), immunoglobulin-G (IgG), and MBP were collected and compared between groups. The CSF-TP, CSF-Alb, CSF-IgG, and CSF/serum quotients of Alb and IgG (Q<sub>Alb</sub>, Q<sub>IgG</sub>) were used to reflect the BBB status. Patients were followed up until December 2020. Cox regression and Kaplan-Meier method were used for survival analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The CSF-TP, CSF-Alb, and CSF-IgG concentrations were significantly higher in patients than controls (p&#x2009;&lt;&#x2009;0.01). Increased CSF-TP and CSF-IgG was found in 45 (39.8%) and 27 (23.9%) ALS patients, while in 7 (58.3%) and 5 (41.7%) ALS-FTD patients. The level of CSF-Alb, CSF-IgG, and CSF-MBP were significantly higher in patients with ALS-FTD than ALS. MBP showed a moderate accuracy in the distinction between ALS-FTD and ALS (AUC&#x2009;=&#x2009;0.715&#x2009;&#xb1;&#x2009;0.101). No difference in MBP was found between patients and controls. Kaplan-Meier analysis indicated that a higher CSF-TP, CSF-IgG, Q<sub>IgG</sub>, or Q<sub>Alb</sub> was significantly associated with shorter survival. Cox regression model showed that CSF-TP, CSF-IgG, and Q<sub>IgG</sub> were independent predictors of survival.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our findings suggested that BBB dysfunction was more prominent in ALS-FTD than ALS and associated with a worse prognosis. Further studies are needed to determine the role of CSF-MBP as a biomarker in ALS.</AbstractText><CopyrightInformation>&#xa9; 2021. Fondazione Societ&#xe0; Italiana di Neurologia.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jin-Yue</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Science &amp; Peking Union Medical College, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Zheng-Yi</ForeName><Initials>ZY</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Science &amp; Peking Union Medical College, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Xiao-Han</ForeName><Initials>XH</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Science &amp; Peking Union Medical College, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Dong-Chao</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Science &amp; Peking Union Medical College, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Xun-Zhe</ForeName><Initials>XZ</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Science &amp; Peking Union Medical College, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Ming-Sheng</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Science &amp; Peking Union Medical College, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Li-Ying</ForeName><Initials>LY</Initials><Identifier Source="ORCID">0000-0001-9223-6659</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Science &amp; Peking Union Medical College, Beijing, 100730, China. pumchcuily@yahoo.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Center, Chinese Academy of Medical Sciences, Beijing, 100730, China. pumchcuily@yahoo.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>XDB39040100</GrantID><Agency>strategic priority research program of the chinese academy of sciences</Agency><Country/></Grant><Grant><GrantID>2014xh0601_A322102</GrantID><Agency>Chinese Academy of Medical Science Neuroscience Center Fund</Agency><Country/></Grant><Grant><GrantID>20141001_A322104</GrantID><Agency>Chinese Academy of Medical Science Neuroscience Center Fund</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Neurol Sci</MedlineTA><NlmUniqueID>100959175</NlmUniqueID><ISSNLinking>1590-1874</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004676">Myelin Basic Protein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001812" MajorTopicYN="N">Blood-Brain Barrier</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004676" MajorTopicYN="N">Myelin Basic Protein</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Blood&#x2013;brain barrier</Keyword><Keyword MajorTopicYN="N">Frontotemporal dementia</Keyword><Keyword MajorTopicYN="N">Myelin basic protein</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>26</Day><Hour>12</Hour><Minute>17</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34826032</ArticleId><ArticleId IdType="doi">10.1007/s10072-021-05731-z</ArticleId><ArticleId IdType="pii">10.1007/s10072-021-05731-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ferrari R, Kapogiannis D, Huey ED, Momeni P (2011) FTD and ALS: a tale of two diseases. Curr Alzheimer Res 8:273&#x2013;94. https://doi.org/10.2174/156720511795563700</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/156720511795563700</ArticleId><ArticleId IdType="pubmed">21222600</ArticleId><ArticleId IdType="pmc">3801195</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney MD, Sagare AP, Zlokovic BV (2018) Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol 14:133&#x2013;150. https://doi.org/10.1038/nrneurol.2017.188</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2017.188</ArticleId><ArticleId IdType="pubmed">29377008</ArticleId><ArticleId IdType="pmc">5829048</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler EA, Sengillo JD, Sagare AP, Zhao Z, Ma Q, Zuniga E, Wang Y, Zhong Z, Sullivan JS, Griffin JH, Cleveland DW, Zlokovic BV (2014) Blood-spinal cord barrier disruption contributes to early motor-neuron degeneration in ALS-model mice. Proc Natl Acad Sci USA 111:E1035-42. https://doi.org/10.1073/pnas.1401595111</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1401595111</ArticleId><ArticleId IdType="pubmed">24591593</ArticleId><ArticleId IdType="pmc">3964055</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S (2015) Alterations of the blood-spinal cord barrier in sporadic amyotrophic lateral sclerosis. Neuropathology 35:518&#x2013;28. https://doi.org/10.1111/neup.12221</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/neup.12221</ArticleId><ArticleId IdType="pubmed">26242689</ArticleId></ArticleIdList></Reference><Reference><Citation>Niebroj-Dobosz I, Janik P, Sokolowska B, Kwiecinski H (2010) Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Eur J Neurol 17:226&#x2013;31. https://doi.org/10.1111/j.1468-1331.2009.02775.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2009.02775.x</ArticleId><ArticleId IdType="pubmed">19796283</ArticleId></ArticleIdList></Reference><Reference><Citation>Saul J, Hutchins E, Reiman R, Saul M, Ostrow LW, Harris BT, Van Keuren-Jensen K, Bowser R, Bakkar N (2020) Global alterations to the choroid plexus blood-CSF barrier in amyotrophic lateral sclerosis. Acta Neuropathol Commun 8:92. https://doi.org/10.1186/s40478-020-00968-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-00968-9</ArticleId><ArticleId IdType="pubmed">32586411</ArticleId><ArticleId IdType="pmc">7318439</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney MD, Zhao Z, Montagne A, Nelson AR, Zlokovic BV (2019) Blood-brain barrier: from physiology to disease and back. Physiol Rev 99:21&#x2013;78. https://doi.org/10.1152/physrev.00050.2017</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00050.2017</ArticleId><ArticleId IdType="pubmed">30280653</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke BE, Patani R (2020) The microglial component of amyotrophic lateral sclerosis. Brain 143:3526&#x2013;3539. https://doi.org/10.1093/brain/awaa309</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa309</ArticleId><ArticleId IdType="pubmed">33427296</ArticleId><ArticleId IdType="pmc">7805793</ArticleId></ArticleIdList></Reference><Reference><Citation>Pehar M, Harlan BA, Killoy KM, Vargas MR (2017) Role and Therapeutic Potential of Astrocytes in Amyotrophic Lateral sclerosis. Curr Pharm Des 23:5010&#x2013;5021. https://doi.org/10.2174/1381612823666170622095802</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612823666170622095802</ArticleId><ArticleId IdType="pubmed">28641533</ArticleId><ArticleId IdType="pmc">5740017</ArticleId></ArticleIdList></Reference><Reference><Citation>Boggs JM (2006) Myelin basic protein: a multifunctional protein. Cell Mol Life Sci 63:1945&#x2013;61. https://doi.org/10.1007/s00018-006-6094-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-006-6094-7</ArticleId><ArticleId IdType="pubmed">16794783</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassall KA, Bamm VV, Harauz G (2015) MyelStones: the executive roles of myelin basic protein in myelin assembly and destabilization in multiple sclerosis. Biochem J 472:17&#x2013;32. https://doi.org/10.1042/BJ20150710</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20150710</ArticleId><ArticleId IdType="pubmed">26518750</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohnert S, Wirth C, Schmitz W, Trella S, Monoranu CM, Ondruschka B, Bohnert M (2021) Myelin basic protein and neurofilament H in postmortem cerebrospinal fluid as surrogate markers of fatal traumatic brain injury. Int J Legal Med. https://doi.org/10.1007/s00414-021-02606-y</Citation></Reference><Reference><Citation>Zavialova MG, Shevchenko VE, Nikolaev EN, Zgoda VG (2017) Is myelin basic protein a potential biomarker of brain cancer? Eur J Mass Spectrom (Chichester) 23:192&#x2013;196. https://doi.org/10.1177/1469066717719810</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1469066717719810</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL (2000) World Federation of Neurology Research Group on Motor Neuron D. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1:293&#x2013;9. https://doi.org/10.1080/146608200300079536</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, van Swieten JC, Seelaar H, Dopper EG, Onyike CU, Hillis AE, Josephs KA, Boeve BF, Kertesz A, Seeley WW, Rankin KP, Johnson JK, Gorno-Tempini ML, Rosen H, Prioleau-Latham CE, Lee A, Kipps CM, Lillo P, Piguet O, Rohrer JD, Rossor MN, Warren JD, Fox NC, Galasko D, Salmon DP, Black SE, Mesulam M, Weintraub S, Dickerson BC, Diehl-Schmid J, Pasquier F, Deramecourt V, Lebert F, Pijnenburg Y, Chow TW, Manes F, Grafman J, Cappa SF, Freedman M, Grossman M, Miller BL (2011) Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134:2456&#x2013;77. https://doi.org/10.1093/brain/awr179</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr179</ArticleId><ArticleId IdType="pubmed">21810890</ArticleId><ArticleId IdType="pmc">3170532</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui B, Cui L, Gao J, Liu M, Li X, Liu C, Ma J, Fang J (2015) Cognitive impairment in Chinese patients with sporadic amyotrophic lateral sclerosis. PLoS One 10:e0137921. https://doi.org/10.1371/journal.pone.0137921</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0137921</ArticleId><ArticleId IdType="pubmed">26367133</ArticleId><ArticleId IdType="pmc">4569418</ArticleId></ArticleIdList></Reference><Reference><Citation>Freedman MS, Thompson EJ, Deisenhammer F, Giovannoni G, Grimsley G, Keir G, Ohman S, Racke MK, Sharief M, Sindic CJ, Sellebjerg F, Tourtellotte WW (2005) Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. Arch Neurol 62:865&#x2013;70. https://doi.org/10.1001/archneur.62.6.865</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.62.6.865</ArticleId><ArticleId IdType="pubmed">15956157</ArticleId></ArticleIdList></Reference><Reference><Citation>Glasner H (1975) Barrier impairment and immune reaction in the cerebrospinal fluid. Eur Neurol 13:304&#x2013;14. https://doi.org/10.1159/000114685</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000114685</ArticleId><ArticleId IdType="pubmed">50234</ArticleId></ArticleIdList></Reference><Reference><Citation>Meucci G, Rossi G, Bettini R, Montanaro D, Gironelli L, Voci L, Bianchi F (1993) Laser nephelometric evaluation of albumin, IgG and alpha 2-macroglobulin: applications to the study of alterations of the blood-brain barrier. J Neurol Sci 118:73&#x2013;8. https://doi.org/10.1016/0022-510x(93)90248-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510x(93)90248-w</ArticleId><ArticleId IdType="pubmed">7693877</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens A, Weller M, Wietholter H (1993) A characteristic ganglioside antibody pattern in the CSF of patients with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 56:361. https://doi.org/10.1136/jnnp.56.4.361</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.56.4.361</ArticleId><ArticleId IdType="pubmed">7683329</ArticleId><ArticleId IdType="pmc">1014951</ArticleId></ArticleIdList></Reference><Reference><Citation>Apostolski S, Nikolic J, Bugarski-Prokopljevic C, Miletic V, Pavlovic S, Filipovic S (1991) Serum and CSF immunological findings in ALS. Acta Neurol Scand 83:96&#x2013;8. https://doi.org/10.1111/j.1600-0404.1991.tb04656.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.1991.tb04656.x</ArticleId><ArticleId IdType="pubmed">2017904</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao X, Yang F, Wang H, Cui F, Li M, Sun B, Li Y, Sun Q, He Z, Li Y, Huang X (2020) The increase in CSF total protein and immunoglobulins in Chinese patients with sporadic amyotrophic lateral sclerosis: A retrospective study. J Neurol Sci 414:116840. https://doi.org/10.1016/j.jns.2020.116840</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.116840</ArticleId><ArticleId IdType="pubmed">32388062</ArticleId></ArticleIdList></Reference><Reference><Citation>Leonardi A, Abbruzzese G, Arata L, Cocito L, Vische M (1984) Cerebrospinal fluid (CSF) findings in amyotrophic lateral sclerosis. J Neurol 231:75&#x2013;8. https://doi.org/10.1007/BF00313720</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00313720</ArticleId><ArticleId IdType="pubmed">6737012</ArticleId></ArticleIdList></Reference><Reference><Citation>Ticozzi N, Tiloca C, Mencacci NE, Morelli C, Doretti A, Rusconi D, Colombrita C, Sangalli D, Verde F, Finelli P, Messina S, Ratti A, Silani V (2013) Oligoclonal bands in the cerebrospinal fluid of amyotrophic lateral sclerosis patients with disease-associated mutations. J Neurol 260:85&#x2013;92. https://doi.org/10.1007/s00415-012-6589-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-012-6589-0</ArticleId><ArticleId IdType="pubmed">22752089</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu CH, Allen K, Oei F, Leoni E, Kuhle J, Tree T, Fratta P, Sharma N, Sidle K, Howard R, Orrell R, Fish M, Greensmith L, Pearce N, Gallo V, Malaspina A (2016) Systemic inflammatory response and neuromuscular involvement in amyotrophic lateral sclerosis. Neurol Neuroimmunol Neuroinflamm 3:e244. https://doi.org/10.1212/NXI.0000000000000244</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000244</ArticleId><ArticleId IdType="pubmed">27308305</ArticleId><ArticleId IdType="pmc">4897985</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu CH, Macdonald-Wallis C, Gray E, Pearce N, Petzold A, Norgren N, Giovannoni G, Fratta P, Sidle K, Fish M, Orrell R, Howard R, Talbot K, Greensmith L, Kuhle J, Turner MR, Malaspina A (2015) Neurofilament light chain: a prognostic biomarker in amyotrophic lateral sclerosis. Neurology 84:2247&#x2013;57. https://doi.org/10.1212/WNL.0000000000001642</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000001642</ArticleId><ArticleId IdType="pubmed">25934855</ArticleId><ArticleId IdType="pmc">4456658</ArticleId></ArticleIdList></Reference><Reference><Citation>Chelstowska B, Kuzma-Kozakiewicz M (2020) Biochemical parameters in determination of nutritional status in amyotrophic lateral sclerosis. Neurol Sci 41:1115&#x2013;1124. https://doi.org/10.1007/s10072-019-04201-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-019-04201-x</ArticleId><ArticleId IdType="pubmed">31897946</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansson O, Janelidze S, Hall S, Magdalinou N, Lees AJ, Andreasson U, Norgren N, Linder J, Forsgren L, Constantinescu R, Zetterberg H, Blennow K, Fs Swedish Bio (2017) Blood-based NfL: a biomarker for differential diagnosis of parkinsonian disorder. Neurology 88:930&#x2013;937. https://doi.org/10.1212/WNL.0000000000003680</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000003680</ArticleId><ArticleId IdType="pubmed">28179466</ArticleId><ArticleId IdType="pmc">5333515</ArticleId></ArticleIdList></Reference><Reference><Citation>Varhaug KN, Torkildsen O, Myhr KM, Vedeler CA (2019) Neurofilament light chain as a biomarker in multiple sclerosis. Front Neurol 10:338. https://doi.org/10.3389/fneur.2019.00338</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00338</ArticleId><ArticleId IdType="pubmed">31024432</ArticleId><ArticleId IdType="pmc">6460359</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattsson N, Cullen NC, Andreasson U, Zetterberg H, Blennow K (2019) Association between longitudinal plasma neurofilament light and neurodegeneration in patients with Alzheimer disease. JAMA Neurol 76:791&#x2013;799. https://doi.org/10.1001/jamaneurol.2019.0765</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2019.0765</ArticleId><ArticleId IdType="pubmed">31009028</ArticleId><ArticleId IdType="pmc">6583067</ArticleId></ArticleIdList></Reference><Reference><Citation>Thouvenot E, Demattei C, Lehmann S, Maceski-Maleska A, Hirtz C, Juntas-Morales R, Pageot N, Esselin F, Alphandery S, Vincent T, Camu W (2020) Serum neurofilament light chain at time of diagnosis is an independent prognostic factor of survival in amyotrophic lateral sclerosis. Eur J Neurol 27:251&#x2013;257. https://doi.org/10.1111/ene.14063</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14063</ArticleId><ArticleId IdType="pubmed">31437330</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodovitch A, Boucraut J, Delmont E, Parlanti A, Grapperon AM, Attarian S, Verschueren A (2021) Combination of serum and CSF neurofilament-light and neuroinflammatory biomarkers to evaluate ALS. Sci Rep 11:703. https://doi.org/10.1038/s41598-020-80370-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-80370-6</ArticleId><ArticleId IdType="pubmed">33436881</ArticleId><ArticleId IdType="pmc">7803734</ArticleId></ArticleIdList></Reference><Reference><Citation>Coatti GC, Frangini M, Valadares MC, Gomes JP, Lima NO, Cavacana N, Assoni AF, Pelatti MV, Birbrair A, de Lima ACP, Singer JM, Rocha FMM, Da Silva GL, Mantovani MS, Macedo-Souza LI, Ferrari MFR, Zatz M (2017) Pericytes extend survival of ALS SOD1 mice and induce the expression of antioxidant enzymes in the murine model and in IPSCs derived neuronal cells from an ALS patient. Stem Cell Rev Rep 13:686&#x2013;698. https://doi.org/10.1007/s12015-017-9752-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-017-9752-2</ArticleId><ArticleId IdType="pubmed">28710685</ArticleId></ArticleIdList></Reference><Reference><Citation>Almutairi MM, Gong C, Xu YG, Chang Y, Shi H (2016) Factors controlling permeability of the blood-brain barrier. Cell Mol Life Sci 73:57&#x2013;77. https://doi.org/10.1007/s00018-015-2050-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-015-2050-8</ArticleId><ArticleId IdType="pubmed">26403789</ArticleId></ArticleIdList></Reference><Reference><Citation>Caroppo P, Le Ber I, Camuzat A, Clot F, Naccache L, Lamari F, De Septenville A, Bertrand A, Belliard S, Hannequin D, Colliot O, Brice A (2014) Extensive white matter involvement in patients with frontotemporal lobar degeneration: think progranulin. JAMA Neurol 71:1562&#x2013;6. https://doi.org/10.1001/jamaneurol.2014.1316</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2014.1316</ArticleId><ArticleId IdType="pubmed">25317628</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Bocchetta M, Heller C, Convery R, Neason M, Moore KM, Cash DM, Thomas DL, Woollacott IOC, Foiani M, Heslegrave A, Shafei R, Greaves C, van Swieten J, Moreno F, Sanchez-Valle R, Borroni B, Laforce R Jr, Masellis M, Tartaglia MC, Graff C, Galimberti D, Rowe JB, Finger E, Synofzik M, Vandenberghe R, de Mendonca A, Tagliavini F, Santana I, Ducharme S, Butler C, Gerhard A, Levin J, Danek A, Frisoni GB, Sorbi S, Otto M, Zetterberg H, Ourselin S, Cardoso MJ, Rohrer JD, On behalf of G, (2019) White matter hyperintensities in progranulin-associated frontotemporal dementia: a longitudinal GENFI study. Neuroimage Clin 24:102077. https://doi.org/10.1016/j.nicl.2019.102077</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2019.102077</ArticleId><ArticleId IdType="pubmed">31835286</ArticleId><ArticleId IdType="pmc">6911860</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Bocchetta M, Cash D, Thomas DL, Woollacott I, Dick KM, van Swieten J, Borroni B, Galimberti D, Masellis M, Tartaglia MC, Rowe JB, Graff C, Tagliavini F, Frisoni G, Laforce R Jr, Finger E, de Mendonca A, Sorbi S, Ourselin S, Cardoso MJ, Rohrer JD, Genetic Ftd Initiative G (2017) White matter hyperintensities are seen only in GRN mutation carriers in the GENFI cohort. Neuroimage Clin 15:171&#x2013;180. https://doi.org/10.1016/j.nicl.2017.04.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2017.04.015</ArticleId><ArticleId IdType="pubmed">28529873</ArticleId><ArticleId IdType="pmc">5429247</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiji M, Takahashi T, Fukuba H, Yamashita H, Kohriyama T, Matsumoto M (2008) White matter lesions in the brain with frontotemporal lobar degeneration with motor neuron disease: TDP-43-immunopositive inclusions co-localize with p62, but not ubiquitin. Acta Neuropathol 116(183):91. https://doi.org/10.1007/s00401-008-0402-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-008-0402-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S, Chung AY, Na JE, Lee SJ, Jeong SH, Kim E, Sun W, Rhyu IJ (1921) Park HC 2019 Myelin degeneration induced by mutant superoxide dismutase 1 accumulation promotes amyotrophic lateral sclerosis. Glia 67:1910. https://doi.org/10.1002/glia.23669</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23669</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y, Tang C, Zhu L, Li J, Liang H, Zhang J, Xu R (2016) The overexpression of TDP-43 protein in the neuron and oligodendrocyte cells causes the progressive motor neuron degeneration in the SOD1 G93A transgenic mouse model of amyotrophic lateral sclerosis. Int J Biol Sci 12:1140&#x2013;9. https://doi.org/10.7150/ijbs.15938</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.15938</ArticleId><ArticleId IdType="pubmed">27570488</ArticleId><ArticleId IdType="pmc">4997058</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorente Pons A, Higginbottom A, Cooper-Knock J, Alrafiah A, Alofi E, Kirby J, Shaw PJ, Wood JD, Highley JR (2020) Oligodendrocyte pathology exceeds axonal pathology in white matter in human amyotrophic lateral sclerosis. J Pathol 251:262&#x2013;271. https://doi.org/10.1002/path.5455</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.5455</ArticleId><ArticleId IdType="pubmed">32391572</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>